Imaging of somatostatin-receptor expressing neuroendocrine tumours with 68Ga-DOTATOC-PET/CT versus 111In-DTPA-octreotide SPECT/CT

被引：0
|
作者：
Oeksuez, M. Oe [1 ]
Aschoff, P. [1 ]
Kemke, B. [1 ]
Rauch, D. [1 ]
Zhernosekov, K. [2 ]
Jennwein, M. [2 ]
Roesch, F. [2 ]
Zoller, W. G. [3 ]
Bihl, H. [1 ]
机构：
[1] Katharinen Hosp, Nucl Med & PET Ctr, D-70174 Stuttgart, Germany
[2] Johannes Gutenberg Univ Mainz, D-55122 Mainz, Germany
[3] Katharinen Hosp, D-70174 Stuttgart, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2005年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S109 / S109
页数：1
相关论文
共 50 条
  • [41] Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours
    I. Buchmann
    M. Henze
    S. Engelbrecht
    M. Eisenhut
    A. Runz
    M. Schäfer
    T. Schilling
    S. Haufe
    T. Herrmann
    U. Haberkorn
    European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34 : 1617 - 1626
  • [42] Prevalence of metastases outside the liver and abdominal lymph nodes on 68Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours
    Wedin, Maria
    Janson, Eva Tiensuu
    Wallin, Goran
    Sundin, Anders
    Daskalakis, Kosmas
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 (05)
  • [43] Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours
    Buchmann, I.
    Henze, M.
    Engelbrecht, S.
    Eisenhut, M.
    Runz, A.
    Schaefer, M.
    Schilling, T.
    Haufe, S.
    Herrmann, T.
    Haberkorn, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (10) : 1617 - 1626
  • [44] Evaluation of 68Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET/CT
    Lino M. Sawicki
    Cornelius Deuschl
    Karsten Beiderwellen
    Verena Ruhlmann
    Thorsten D. Poeppel
    Philipp Heusch
    Harald Lahner
    Dagmar Führer
    Andreas Bockisch
    Ken Herrmann
    Michael Forsting
    Gerald Antoch
    Lale Umutlu
    European Radiology, 2017, 27 : 4091 - 4099
  • [45] Evaluation of 68Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET/CT
    Sawicki, Lino M.
    Deuschl, Cornelius
    Beiderwellen, Karsten
    Ruhlmann, Verena
    Poeppel, Thorsten D.
    Heusch, Philipp
    Lahner, Harald
    Fuehrer, Dagmar
    Bockisch, Andreas
    Herrmann, Ken
    Forsting, Michael
    Antoch, Gerald
    Umutlu, Lale
    EUROPEAN RADIOLOGY, 2017, 27 (10) : 4091 - 4099
  • [46] Impact of 111In-DTPA-octreotide SPECT/CT fusion images in the management of neuroendocrine tumours [Impatto della fusione di immagini SPECT/TC con 111In-DTPA- octreotide nel management dei tumori neuroendocrini]
    Castaldi P.
    Rufini V.
    Treglia G.
    Bruno I.
    Perotti G.
    Stifano G.
    Barbaro B.
    Giordano A.
    La radiologia medica, 2008, 113 (7) : 1056 - 1067
  • [47] Impact of peptide receptor radionuclide therapy on the 68Ga-DOTATOC-PET/CT uptake in normal tissue
    Giesel, F. L.
    Stefanova, M.
    Schwartz, L. H.
    Afshar-Oromieh, A.
    Eisenhut, M.
    Haberkorn, U.
    Kratochwil, C.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 57 (02): : 171 - 176
  • [48] The Role of 68Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on 111In-DTPA-Octreotide Scintigraphy
    Srirajaskanthan, Rajaventhan
    Kayani, Irfan
    Quigley, Anne Marie
    Soh, Jade
    Caplin, Martyn E.
    Bomanji, Jamshed
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (06) : 875 - 882
  • [49] Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours:: comparison of 86Y-DOTATOC and 111In-DTPA-octreotide
    Förster, GJ
    Engelbach, M
    Brockmann, J
    Reber, H
    Buchholz, HG
    Mäcke, HR
    Rösch, F
    Herzog, H
    Bartenstein, P
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (12) : 1743 - 1750
  • [50] Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of 86Y-DOTATOC and 111In-DTPA-octreotide
    Gregor J. Förster
    Martin Engelbach
    Jörg Brockmann
    Helmut Reber
    Hans-Georg Buchholz
    Helmut R. Mäcke
    Frank Rösch
    Hans Herzog
    Peter Bartenstein
    European Journal of Nuclear Medicine, 2001, 28 : 1743 - 1750
12345